The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 3,001–3,200 of 3,517
Antonelli, T., Ferioli, V., Gallo, G. L., Tomasini, M. C., Fernández, M., O'Connor, W. T., Glennon, J. C., Tanganelli, S., & Ferraro, L. (2000) · Synapse · doi:10.1002/1098-2396(20001201)38:3<355::aid-syn15>3.0.co;2-e · Cited by 39
Matrenza, C., Hughes, J.-M., Kemp, A. H., Wesnes, K. A., Harrison, B. J., & Nathan, P. J. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040215 · Cited by 39
Brain Stimulation for Neurological and Psychiatric Disorders, Current Status and Future Direction
Chang, J.-Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049718 · Cited by 39
Muller, M. J., Szegedi, A., Wetzel, H., & Benkert, O. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006856 · Cited by 39
Villarroya, M., Garcı́a, A. G., & Marco, J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383368 · Cited by 39
Szymanska, A., Rabe‐Jabłońska, J., & Karasek, M. (2001) · PubMed · Cited by 39
Treatment-Resistant Depression: New Therapies on the Horizon
Trivedi, M. H. (2003) · Annals of Clinical Psychiatry · doi:10.3109/10401230309085670 · Cited by 39
Hormonal interventions with psychopharmacological potential: an overview.
Halbreich, U. M. (1997) · PubMed · Cited by 38
Heinz, A., Jones, D. W., Zajicek, K. B., Gorey, J. G., Juckel, G., Higley, J. D., & Weinberger, D. R. (2004) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0579-5_4 · Cited by 38
Antidepressant effectiveness in severe depression and melancholia.
Schatzberg, A. F. (1999) · PubMed · Cited by 38
Hatanaka, K.-I., Nomura, T., Hidaka, K., Takeuchi, H., Yatsugi, S., Fujii, M., & Yamaguchi, T. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00079-2 · Cited by 38
Gobert, A., Dekeyne, A., & Millan, M. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00229-4 · Cited by 38
Self-citationEffects of electroconvulsive therapy on plasma vasopressin and oxytocin
Devanand, D. P., Lisanby, S. H., Lo, E., Fitzsimons, L., Cooper, T. B., Halbreich, U. M., & Sackeïm, H. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00086-9 · Cited by 38
5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus
Daws, L. C., Gerhardt, G. A., & Frazer, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00277-3 · Cited by 38
Antidepressant Drug Discovery in the Postgenomic Era
Holsboer, F. (2001) · The World Journal of Biological Psychiatry · doi:10.3109/15622970109026805 · Cited by 38
Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus
Kang, U. G., Roh, M., Jung, J.-R., Shin, S. Y., Lee, Y. H., Park, J.-B., & Kim, Y. S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00173-8 · Cited by 38
Perez, M., Pauwels, P. J., Fourrier, C., Chopin, P., Valentin, J., John, G. W., Marien, M. R., & Halazy, S. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00090-0 · Cited by 38
Segrave, R. A., & Nathan, P. J. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.672 · Cited by 38
Resynchronisation of a diurnal rodent circadian clock accelerated by a melatonin agonist
Reeth, O. V., Olivares, E., Turek, F. W., Granjon, L., & Mocaër, E. (1998) · Neuroreport · doi:10.1097/00001756-199806010-00043 · Cited by 38
Husum, H., Gruber, S. H. M., Bolwig, T. G., et al. (2002) · Neuropeptides · doi:10.1016/s0143-4179(02)00086-0 · Cited by 38
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig
Pullar, I. A., Boot, J. R., Broadmore, R. J., Eyre, T. A., Cooper, J., Sanger, G. J., Wedley, S., & Mitchell, S. N. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.029 · Cited by 38
INTERACTIONS BETWEEN δ OPIOID RECEPTORS AND α2A‐ADRENOCEPTORS
Rios, C., Gomes, I., & Devi, L. A. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.04076.x · Cited by 38
A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients
van den Broek, W. W., Birkenhäger, T. K., Mulder, P. G. H., Bruijn, J. A., & Moleman, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1853-3 · Cited by 38
Perspectives on the use of anticonvulsants in the treatment of bipolar disorder
Brambilla, P., Barale, F., & Soares, J. C. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002668 · Cited by 38
Kg, L., Pl, M., & Bartholini, G. (1987) · PubMed · Cited by 38
Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine
Linet, L. S. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.803b · Cited by 38
Care of the sexually active depressed patient.
Hirschfeld, R. M. A. (1999) · PubMed · Cited by 37
Gannon, R. L., & Millan, M. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.059 · Cited by 37
Self-citationExpression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock
Burnet, P. W. J., Sharp, T., LeCorre, S., & Harrison, P. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00857-5 · Cited by 37
Does tolerance develop to the sedative and amnesic effects of antidepressants?
Sakulsripong, M., Curran, H. V., & LADER, M. H. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315137 · Cited by 37
Thyroid Hormone Levels and Recurrence of Major Depression
Joffe, R. T., & Marriott, M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1689 · Cited by 37
Sleight, A. J., Marsden, C. A., Palfreyman, M. G., Mir, A. K., & Lovenberg, W. M. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90199-9 · Cited by 37
Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?
Obuchowicz, E., Krysiak, R. G., & Herman, Z. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.08.006 · Cited by 37
Piñeyro, G., Deveault, L., Blier, P., Dennis, T., & de Montigny, C. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169324 · Cited by 37
Future Options for Combination Therapy in the Management of Erectile Dysfunction in Older Men
Sommer, F. O., & Engelmann, U. H. (2004) · Drugs & Aging · doi:10.2165/00002512-200421090-00001 · Cited by 37
The Efficacy of Intramuscular Tramadol as a Rapid-Onset Antidepressant
Spencer, C. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/000486740003400101 · Cited by 37
Effects of Sodium Valproate on Corticotropin-Releasing Factor Systems in Rat Brain
Stout, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00243-8 · Cited by 37
Romero, L. I., Celada, P., Martín‐Ruiz, R., Díaz-Mataix, L., Mourelle, M., Delgadillo, J., Hervás, I., & Artigas, F. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300062 · Cited by 37
Bourin, M., Redrobe, J. P., & Baker, G. B. (1998) · Psychopharmacology · doi:10.1007/s002130050560 · Cited by 37
Gavioli, E. C., Canteras, N. S., & de Lima, T. C. M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00054-2 · Cited by 37
Zhong, P., & Yan, Z. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.072 · Cited by 37
Combined Treatment with Imipramine and Mianserin
Lauritzen, L., Clemmesen, L., Klysner, R., Loldrup, D., Lunde, M., Schaumburg, E., Waarst, S., & Bech, P. (1992) · Pharmacopsychiatry · doi:10.1055/s-2007-1014403 · Cited by 37
The Effects of Tianeptine and other Antidepressants on a Rat Model of Depression
Curzon, G., Kennett, G. A., Sarna, G. S., & Whitton, P. S. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296682 · Cited by 37
SNRIs in the management of acute major depressive disorder.
Zajecka, J., & Albano, D. (2004) · PubMed · Cited by 36
Pharmacological principles of antidepressant efficacy
Schatzberg, A. F. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.399 · Cited by 36
Facilitation of cognitive functions by a specific α2-adrenoceptor antagonist, atipamezole
Haapalinna, A., Sirviö, J., & Lammintausta, R. A. S. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00077-6 · Cited by 36
Increased 5-HT2 receptor-mediated behavior 11 days after shock in learned helplessness rats
Nankai, M., Yamada, S., Muneoka, K., & Toru, M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00222-7 · Cited by 36
Parekh, P. I., Ketter, T. A., Altshuler, L. L., Frye, M. A., Callahan, A., Marangell, L. B., & Post, R. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00513-1 · Cited by 36
Madhav, T. R., Pei, Q., Grahame-Smith, D. G., & Zetterström, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00083-x · Cited by 36
Martínez-Raga, J., Keaney, F., Sutherland, G., Gálvez, B. P., & Strang, J. (2003) · Addiction Biology · doi:10.1080/1355621031000069837 · Cited by 36
New directions for erectile dysfunction therapies
Ke, A., & Hedlund, P. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900797 · Cited by 36
Heterogeneity of Antidepressant Binding Sites on the Recombinant Rat Serotonin Transporter SERT1
Schloss, P. D., & Betz, H. (1995) · Biochemistry · doi:10.1021/bi00039a014 · Cited by 36
The effects of antidepressants on psychomotor function with particular reference to reboxetine
Hindmarch, I. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00416-1 · Cited by 36
Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS)
George, M. S., Nahas, Z. H., Li, X., Kozel, F. A., Anderson, B. S., Yamanaka, K., Chae, J., & Foust, M. J. (2002) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2002.35229 · Cited by 36
Fournier, G. N., Materi, L. M., Semba, K., & Rasmusson, D. D. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.021 · Cited by 36
Spooren, W. P. J. M., Mombereau, C., Maco, M., Gill, R., Kemp, J. A., Ozmen, L., Nakanishi, S., & Higgins, G. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1785-y · Cited by 36
Prevot, E., Maudhuit, C., Poul, E. L., Hamon, M., & ADRIEN, J. (1996) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1996.00238.x · Cited by 36
Transcranial Magnetic Stimulation: Applications for Neuropsychopharmacology
Kähkönen, S., & Ilmoniemi, R. J. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042631 · Cited by 36
Proietto, J., Fam, B. C., Ainslie, D. A., & Thorburn, A. W. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.6.1317 · Cited by 36
O’Donnell, J. M., Frith, S. A., & Wilkins, J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22769-0 · Cited by 36
Discriminative stimulus properties of antidepressant agents: a review.
Dekeyne, A., & Millan, M. J. (2003) · PubMed · doi:10.1097/01.fbp.0000089141.24369.07 · Cited by 36
Self-citationFactors contributing to failed trials of new agents: can technology prevent some problems?
Greist, J. H., Mundt, J. C., & Kobak, K. A. (2002) · PubMed · Cited by 36
Schatzberg, A. F. (2003) · PubMed · Cited by 35
The dual-action hypothesis: does pharmacology matter?
Shelton, R. C. (2004) · PubMed · Cited by 35
Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients
Delgado, P. L., Moreno, F., Onate, L., & Gelenberg, A. J. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002778 · Cited by 35
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
Lotrich, F. E., & Pollock, B. G. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.1.1.17.52301 · Cited by 35
Lea, P. M., & Faden, A. I. (2003) · Drug News & Perspectives · doi:10.1358/dnp.2003.16.8.829350 · Cited by 35
Sleep deprivation in depression
Eichhammer, P., Kharraz, A., Wiegand, R., Langguth, B., Frick, U., Aigner, J. M., & Hajak, G. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01479-0 · Cited by 35
Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex
Hughes, Z. A., & Stanford, S. C. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00715-7 · Cited by 35
Dopamine agonists in Parkinson?s disease
Tintner, R., & Jankovic, J. J. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.11.1803 · Cited by 35
Regulation of Vasopressin V1b Receptors and Stress Adaptation
Volpi, S., Rabadan‐Diehl, C., & Aguilera, G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.035 · Cited by 35
Fink, K., Schmitz, V., B�ing, C., & G�thert, M. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00172776 · Cited by 35
NPY-induced inhibition of male copulatory activity is a direct behavioural effect
Poggioli, R., Vergoni, A. V., Marrama, D., Giuliani, D., & Bertolini, A. (1990) · Neuropeptides · doi:10.1016/0143-4179(90)90130-q · Cited by 35
Garcia, A. S., Barrera, G., Burke, T. F., Ma, S., Hensler, J. G., & Morilak, D. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02748.x · Cited by 35
Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression
Lloyd, R. L., Pekary, A. E., Sattin, A., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00555-x · Cited by 35
González, M. I., Farabollini, F., Albonetti, E., & Wilson, C. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90164-3 · Cited by 35
Escitalopram in clinical practice: Results of an open-label trial in a naturalistic setting
Rush, A. J., & Bose, A. (2005) · Depression and Anxiety · doi:10.1002/da.20051 · Cited by 35
Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram
Wilson, S. J., Bailey, J. E., Rich, A. S., Adrover, M., Potokar, J., & Nutt, D. J. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.11.004 · Cited by 35
Nitric oxide donors inhibit 5‐hydroxytryptamine (5‐HT) uptake by the human 5‐HT transporter (SERT)
Bryan‐Lluka, L. J., Papacostas, M. H., Paczkowski, F. A., & Wanstall, J. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705904 · Cited by 35
Lee, M. D., Somerville, E. M., Kennett, G. A., Dourish, C. T., & Clifton, P. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03406.x · Cited by 35
Effect of repeated treatment with tianeptine and fluoxetine on the central α1-adrenergic system
Rogóż, Z., Skuza, G., Dlaboga, D., Maj, J., & Dziedzicka‐Wasylewska, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00079-x · Cited by 35
Nickola, T. J., Ignatowski, T. A., Reynolds, J. L., & Spengler, R. N. (2001) · PubMed · Cited by 35
Trick, L., Stanley, N., Rigney, U., & Hindmarch, I. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042622 · Cited by 34
Shelton, C. I. (2004) · PubMed · Cited by 34
Blendy, J. A., Grimm, L., Perry, D., West-Johnsrud, L., & Kellar, K. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02580.1990 · Cited by 34
5HT 7 Receptors in the Rodent Suprachiasmatic Nucleus
Gannon, R. L. (2001) · Journal of Biological Rhythms · doi:10.1177/074873040101600103 · Cited by 34
L-DOPA increases noradrenaline turnover in central and peripheral nervous systems
Dayan, L., & Finberg, J. P. M. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00190-4 · Cited by 34
Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D2/D3 receptors
Dziedzicka‐Wasylewska, M., Rogóż, Z., Skuza, G., Dlaboga, D., & Maj, J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200203000-00004 · Cited by 34
GABAB receptor subunits, R1 and R2, in brainstem catecholamine and serotonin neurons
Burman, K. J., Ige, A. O., White, J. H. M., Marshall, F. H., Pangalos, M. N., Emson, P. C., Minson, J. B., & Llewellyn‐Smith, I. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04269-5 · Cited by 34
Crews, F. T., Scott, J. A., & Shorstein, N. H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90082-5 · Cited by 34
Phytoestrogens: are they really estrogen mimics?
Naftolin, F. N., & Stanbury, M. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02006-4 · Cited by 34
Ropinirole for antidepressant-induced sexual dysfunction
Worthington, J. J., Simon, N. M., Korbly, N. B., Perlis, R. H., & Pollack, M. H. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00006 · Cited by 34
Substance P promotes sleep in the ventrolateral preoptic area of rats
Zhang, G., Wang, L., Liu, H., & Zhang, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.017 · Cited by 34
Effect of pindolol on hormone secretion and body temperature: Partial agonist effects
Meltzer, H. Y., & Maes, M. H. J. (1996) · Journal of Neural Transmission · doi:10.1007/bf01292618 · Cited by 34
Role of the lateral septal noradrenergic system in the elaboration of male sexual behavior in rats
Gulia, K. K., Kumar, V. M., & Mallick, H. N. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00771-2 · Cited by 34
de Groote, L., Olivier, B., & Westenberg, H. G. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01417-6 · Cited by 34
Penttilä, J., Kajander, J., Aalto, S., Hirvonen, J., Någren, K., Ilonen, T., Syvälahti, E. K. G., & Hietala, J. A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570400450x · Cited by 34
Review : Serotonin Transporter and Psychiatric Disorders: Listening to the Gene
Lesch, K. (1998) · The Neuroscientist · doi:10.1177/107385849800400110 · Cited by 34
Rodrı́guez–Manzo, G., López‐Rubalcava, C., Hen, R., & Fernández‐Guasti, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704827 · Cited by 34
Zhao, Y., Zhang, H., & O’Donnell, J. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053215 · Cited by 34
EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans
McAllister-Williams, H., & Massey, A. E. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1339-0 · Cited by 34
Millan, M. J., Brocco, M., Rivet, J., Audinot, V., Newman‐Tancredi, A., Maiofiss, L., Queriaux, S., Despaux, N., Péglion, J.-L., & Dekeyne, A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35260-7 · Cited by 34
Self-citationMatrisciano, F., Scaccianoce, S., Bianco, P. D., Panaccione, I., Canudas, A. M., Battaglia, G., Riozzi, B., Ngomba, R. T., Molinaro, G., Tatarelli, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03141.x · Cited by 33
Artigas, F. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.180 · Cited by 33
Lundkvist, G. B. S., Kristensson, K., & Hill, R. H. (2002) · Journal of Biological Rhythms · doi:10.1177/074873002129002320 · Cited by 33
Lejeune, F., Gobert, A., & Millan, M. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02476-9 · Cited by 33
Self-citationWu, M., Hajszán, T., Xu, C., Léránth, C., & Alreja, M. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00180.2004 · Cited by 33
Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus
Weiner, E. D., Mallat, A. M., Papolos, D. F., & Lachman, H. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90086-q · Cited by 33
Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression
Gründer, G., Wetzel, H., Hammes, E., & Benkert, O. (1993) · Psychopharmacology · doi:10.1007/bf02257418 · Cited by 33
Stahl, S. M., Kaiser, L., Roeschen, J., Hesselink, J. M. K., & Orazem, J. P. (1998) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145798001059 · Cited by 33
Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant
Akunne, H. C., Zoski, K. T., Whetzel, S. Z., Cordon, J. J., Brandon, R. M., Roman, F. J., & Pugsley, T. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00049-1 · Cited by 33
Neurovegetative symptoms in chronic pain and depression
Davidson, J. R. T., Krishma, R., France, R. D., & Pelton, S. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90050-3 · Cited by 33
Finta, E. P., Regenold, J. T., & Illés, P. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171093 · Cited by 33
Cremers, T. I. F. H., Wiersma, L. J., Bosker, F. J., den Boer, J. A., Westerink, B. H. C., & Wikström, H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01093-3 · Cited by 33
Ninan, P. T., Rush, A., Crits-Christoph, P., Kornstein, S., Manber, R., Thase, M., Trivedi, M., Rothbaum, B. O., Zajecka, J., Borian, F. E., et al. (2002) · Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0510 · Cited by 33
Monti, J. M., & Jantos, H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.039 · Cited by 33
Faith, M. S., Calamaro, C., Dolan, M. S., & Pietrobelli, A. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200401000-00003 · Cited by 33
Monti, J. M., & Jantos, H. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.08.023 · Cited by 33
Therapeutic Monitoring of Antidepressants in the Era of Pharmacogenetics Studies
Eap, C. B., Sirot, E. J., & Baumann, P. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00011 · Cited by 33
O’Reardon, J. P., Chopra, M. P., Bergan, A., Gallop, R., DeRubeis, R. J., & Crits-Christoph, P. F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.020 · Cited by 33
Beck, J., Biały, M., & Kostowski, W. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00678-9 · Cited by 33
Veening, J. G., Coolen, L. M., Spooren, W., Joosten, H., van Oorschot, R., Mos, J., Ronken, E., & Olivier, B. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00072-2 · Cited by 33
Federici, M., Geracitano, R., Tozzi, A., Longone, P., Angelantonio, S. D., Bengtson, C. P., Bernardi, G., & Mercuri, N. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007427 · Cited by 33
van Praag, H. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022115 · Cited by 33
Central noradrenergic control of penile erection
Giuliano, F., & Rampin, O. (2000) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900509 · Cited by 33
Rabiner, E. A., Bhagwagar, Z., Gunn, R. N., Cowen, P. J., & Grasby, P. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300472 · Cited by 33
Comparing the Methods Used to Compare Antidepressants
Thase, M. E. (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.6844 · Cited by 33
(2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7867-8 · Cited by 33
MILWAIN, E., & Nagy, Z. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080971 · Cited by 32
Kopp, C., Vogel, E., Rettori, M., Delagrange, P., Renard, P., Lesieur, D., & Misslin, R. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00071-4 · Cited by 32
Kp, D., & Curzon, G. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90138-s · Cited by 32
Focus on Antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?
Stahl, S. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004146 · Cited by 32
Sertraline-Induced Anorgasmia Treated With Intermittent Nefazodone
Reynolds, R. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0206f · Cited by 32
Popoli, M., Mori, S., Brunello, N., Perez, J., Gennarelli, M., & Racagni, G. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00108-x · Cited by 32
Neuropeptide y, gaba and circadian phase shifts to photic stimuli
Lall, G. S., & Biello, S. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00396-8 · Cited by 32
la Cour, C. M., Hanoun, N., Melfort, M., Hen, R., Lesch, K., Hamon, M., & Lanfumey, L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02367.x · Cited by 32
Use of knock-out mice to determine the molecular basis for the actions of nicotine
Picciotto, M. R., Zoli, M., & Changeux, J. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011931 · Cited by 32
Kraus, M. M., & Prast, H. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01735.x · Cited by 32
Smith, S. M., Lindefors, N., Hurd, Y. L., et al. (1995) · Psychopharmacology · doi:10.1007/bf02311181 · Cited by 32
Nomikos, G. G., Zis, A. P., Damsma, G., & Fibiger, H. C. (1991) · Psychopharmacology · doi:10.1007/bf02244315 · Cited by 32
Lejeune, F., Gobert, A., Rivet, J., & Mark, J. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91490-7 · Cited by 32
A Causative Factor of Copulatory Disorder in Rats Following Social Stress
Niikura, S., Yokoyama, O., Komatsu, K., YOTSUYANAGI, S., Mizuno, T., & Namiki, M. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64754-4 · Cited by 32
Tamiz, A. P., Bandyopadhyay, B. C., Zhang, J., Flippen-Anderson, J. L., Zhang, M., Wang, C. Z., Johnson, K. M., Tella, S. R., & Kozikowski, A. P. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000552s · Cited by 32
Applying proteomics to signaling networks
Kabuyama, Y., Resing, K. A., & Ahn, N. G. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.001 · Cited by 32
Buccafusco, J. J., Terry, A. V., Goren, T., & Blaugrun, E. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00937-5 · Cited by 32
The adverse effects of antidepressants
Mir, S., & Taylor, D. M. (1997) · Current Opinion in Psychiatry · doi:10.1097/00001504-199703000-00006 · Cited by 32
Bouwer, C., & Stein, D. J. (1997) · PubMed · Cited by 31
Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
Young, R. C., Mattis, S. A., Alexopoulos, G. S., Meyers, B. S., Shindledecker, R. D., & Dhar, A. K. (1991) · PubMed · Cited by 31
α7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum
Aznar, S., Kostova, V., Christiansen, S. H., & Knudsen, G. M. (2005) · Synapse · doi:10.1002/syn.20108 · Cited by 31
Lejeune, F., & Millan, M. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01383-9 · Cited by 31
Self-citationGifkins, A., Greba, Q., & Kokkinidis, L. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.5.785 · Cited by 31
van der Sandt, I. C. J., Smolders, R., Nabulsi, L., Zuideveld, K. P., de Boer, A. G., & Breimer, D. D. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00150-6 · Cited by 31
Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression
FUENTE, J. M. D. L., & Mendlewicz, J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90041-w · Cited by 31
Tianeptine and its enantiomers: effects on spatial memory in rats with medial septum lesions
Morris, R., Kelly, S., Burney, D., Anthony, T., Boyer, P., & Spedding, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00058-2 · Cited by 31
Gartside, S. E., Ellis, P. M., Sharp, T., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90768-y · Cited by 31
Price, C. S., & Taylor, F. B. (2005) · Depression and Anxiety · doi:10.1002/da.20075 · Cited by 31
Kohlmeier, K. A., Burns, J., Reiner, P. B., & Semba, K. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01829.x · Cited by 31
Nicotinic Acetylcholine Receptor-Mediated [3H]Dopamine Release from Hippocampus
Cao, Y., Surowy, C. S., & Puttfarcken, P. S. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076794 · Cited by 31
Neurokinin NK1- and NK3-immunoreactive neurons in serotonergic cell groups in the rat brain
Léger, L., Gay, N., & Cespuglio, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02543-5 · Cited by 31
Klint, T., & Larsson, K. (1995) · Psychopharmacology · doi:10.1007/bf02246293 · Cited by 31
Cassano, G., Heinze, G., Löo, H., MENDLEWICZ, J., & de Sousa, M. P. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)82332-7 · Cited by 31
Broocks, A., Little, J. T., Martin, A. D., Minichiello, M. D., Dubbert, B., Mack, C., Tune, L. E., Murphy, D. L., & Sunderland, T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00388-0 · Cited by 31
Larraya, C., Guillard, J., Renard, P., Audinot, V., Boutin, J. A., Delagrange, P., Bennejean, C., & Viaud‐Massuard, M. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.03.005 · Cited by 31
Durlach-Misteli, C., & Van, J. M. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90505-x · Cited by 31
How common are habitable planets?
Lissauer, J. (1999) · Nature · doi:10.1038/35011503 · Cited by 30
Dziedzicka‐Wasylewska, M., & Rogo, R. (1995) · Journal of Neural Transmission · doi:10.1007/bf01281156 · Cited by 30
Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT)
Mochizuki, H., Amano, T., Seki, T., Matsubayashi, H., Mitsuhata, C., Morita, K., Kitayama, S., Dohi, T., Mishima, H. K., & Sakai, N. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.08.008 · Cited by 30
Johanson, J. F. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00550.x · Cited by 30
Wu, M., Hrycyshyn, A. W., & Brudzyński, S. M. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00859-1 · Cited by 30
Beaufour, C., Bihan, C. L., Hamon, M., & Thiébot, M.-H. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00492-0 · Cited by 30
Tianeptine and fluoxetine in major depression: a 6‐week randomised double‐blind study
Novotný, V., & Faltus, F. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.411 · Cited by 30
Excitatory effects of muscarine on septohippocampal neurons: involvement of M3 receptors
Liu, W., Kumar, A., & Alreja, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00729-x · Cited by 30
Zhou, J., He, R. L., Johnson, K. M., Ye, Y., & Kozikowski, A. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040117o · Cited by 30
Tordera, R. M., Monge, A., Rı́o, J. D., & Lasheras, B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01504-2 · Cited by 30
Neckelmann, D., Bjørkum, A. A., Bjorvatn, B., & Ursin, R. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00204-5 · Cited by 30
Hertel, P., Nomikos, G. G., & Svensson, T. H. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00045-3 · Cited by 30
Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats
Muriel, M., Orieux, G., & Hirsch, É. C. (2002) · Movement Disorders · doi:10.1002/mds.10256 · Cited by 30
van der Hart, M. G. C., de Biurrun, G., Czéh, B., Rupniak, N. M. J., den Boer, J. A., & Fuchs, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2260-0 · Cited by 30
Januel, D., Poirier, M.-F., D'alche-Biree, F., Dib, M., & Olié, J.-P. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00086-1 · Cited by 30
Inhibitory Neurotransmitters and Nociception: Role of GABA and Glycine
Hammond, D. L. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60777-6_14 · Cited by 30
Lithium Augmentation of Venlafaxine: An Open-Label Trial
Hoencamp, E., Haffmans, P. M. J., Dijken, W. A., & Huijbrechts, I. P. A. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00008 · Cited by 30
Butyrylcholinesterase-Mediated Enhancement of the Enzymatic Activity of Trypsin
Darvesh, S., Kumar, R., Roberts, S., Walsh, R., & Martin, E. V. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1010947205224 · Cited by 29
Tellez, S., Colpaert, F. C., & Marien, M. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00110-7 · Cited by 29
The effects of noradrenergic re-uptake inhibition on memory encoding in man
Papps, B. P., Shajahan, P. M., Ebmeier, K. P., & O’Carroll, R. E. (2001) · Psychopharmacology · doi:10.1007/s00213-001-0924-y · Cited by 29
Noda, K., Anzai, T., Ogata, M., Akita, H., Ogura, T., & Saji, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03330-4 · Cited by 29
Kang, S., Wu, Y., An, N., & Ren, M. F. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90024-0 · Cited by 29
Choline rise in the rat hippocampus induced by electroconvulsive shock treatment
Sartorius, A., Neumann‐Haefelin, C., Vollmayr, B., Hoehn, M., & Henn, F. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01600-1 · Cited by 29
Owesson, C. Å., Seif, I., McLaughlin, D. P., & Stamford, J. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02724.x · Cited by 29
5-HT 2C receptors are involved in the discriminative stimulus effects of citalopram in rats
Millan, M. J., Girardon, S., & Dekeyne, A. (1999) · Psychopharmacology · doi:10.1007/s002130050910 · Cited by 29
Self-citationRegulation of Antidepressant Activity by cAMP Response Element Binding Proteins
Conti, A. C., & Blendy, J. A. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:2:143 · Cited by 29
Jarrett, D. B., Miewald, J. M., Fedorka, I. B., Coble, P. A., Kupfer, D. J., & Greenhouse, J. B. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90029-1 · Cited by 29
Vardenafil reverses erectile dysfunction induced by paroxetine in rats
Angulo, J., Bischoff, E., Gabancho, S., Cuevas, P., & de Tejada, I. S. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900950 · Cited by 29
Impaired release of β-endorphin in response to serotonin in a rat model of depression
Zangen, A., Nakash, R., Roth‐Deri, I., Overstreet, D. H., & Yadid, G. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00612-1 · Cited by 29
Nagatani, T., Yamamoto, T., Sugihara, T., & Ueki, S. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90648-0 · Cited by 29
Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment
Mizoguchi, K., Yuzurihara, M., Nagata, M., Ishige, A., Sasaki, H., & Tabira, T. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00747-5 · Cited by 29
GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions
McAllister, K. H. M., & Pratt, J. A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00405-1 · Cited by 29
Mitchell, S. N., Greenslade, R. G., & Cooper, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01469-8 · Cited by 29
Ryckmans, T., Berton, O., Grimée, R., Kogej, T., Lamberty, Y., Pasau, P., Talaga, P. E., & Génicot, C. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00563-2 · Cited by 29
Skuza, G., & Rogóż, Z. (2003) · PubMed · Cited by 29
Marinković, J. (2008) · Springer eBooks · doi:10.1007/978-1-4020-5614-7_2264 · Cited by 29
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.